Benign neoplasm of endocrine pancreas
ICD-10 D13.7 is a billable code used to indicate a diagnosis of benign neoplasm of endocrine pancreas.
Benign neoplasms of the endocrine pancreas, such as insulinomas and gastrinomas, are rare tumors that arise from the hormone-producing cells of the pancreas. These tumors are typically well-circumscribed and can be asymptomatic or cause symptoms related to hormone overproduction. Insulinomas, for example, can lead to hypoglycemia due to excessive insulin secretion, while gastrinomas can cause Zollinger-Ellison syndrome, characterized by recurrent peptic ulcers. Diagnosis often involves imaging studies such as CT scans or MRIs, along with biochemical tests to assess hormone levels. Although benign, these neoplasms require careful monitoring due to their potential for local invasion or, in rare cases, malignant transformation. Regular follow-up with imaging and clinical evaluation is essential to ensure that any changes in size or behavior are promptly addressed.
Detailed hormonal assay results and imaging studies.
Patients presenting with hypoglycemia or recurrent ulcers.
Ensure accurate documentation of hormone levels and any surgical interventions.
Operative reports detailing tumor excision and pathology results.
Surgical removal of insulinomas or gastrinomas.
Document the extent of resection and any complications during surgery.
Used when a patient with a suspected pancreatic neoplasm undergoes laparoscopic evaluation.
Operative report detailing findings and any interventions.
Ensure that the surgical specialty documents the nature of the neoplasm.
Common symptoms include hypoglycemia, abdominal pain, and symptoms related to excessive hormone production, such as peptic ulcers in the case of gastrinomas.
